Live Breaking News & Updates on Immunotoxicology Endpoints

Stay updated with breaking news from Immunotoxicology endpoints. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Considerations for Immunology and Immunotoxicology Endpoints in Early Drug Development, Upcoming Webinar Hosted by Xtalks


Considerations for Immunology and Immunotoxicology Endpoints in Early Drug Development, Upcoming Webinar Hosted by Xtalks
Share Article
In this free webinar, the featured speakers will discuss immunology and immunotoxicology endpoints and how to assess the immune response in early drug development. The presentation will explore the range of immunology endpoint assessments available and their respective uses for developing safe and effective therapeutics.
This talk will outline when to consider different I&I assay services and the regulatory and scientific considerations for these that will influence the appropriate biological interpretation of the immune response.
TORONTO, Ontario (PRWEB)
April 06, 2021
There are many considerations for Immunology and Immunotoxicology (I&I) assessments that are needed during the early phase of drug development. This talk will outline when to consider differe ....

United Kingdom , James Munday , Ayesha Rashid , Chris Cooper , Immunotoxicology Endpoints In Early Drug Development , Honeycomb Worldwide Inc , Subject Matter Expert , Immunotoxicology Endpoints , Early Drug , Life Science , ஒன்றுபட்டது கிஂக்டம் , ஜேம்ஸ் முண்டே , ஆயிஷா ரஷித் , கிறிஸ் கூப்பர் , தேன்கூடு உலகளவில் இன்க் , பொருள் விஷயம் நிபுணர் , ஆரம்ப மருந்து , வாழ்க்கை அறிவியல் ,